KR20180001652A - Cosmetic composition for skin barrier comprising extract of Buddleia officinalis or fractions thereof - Google Patents

Cosmetic composition for skin barrier comprising extract of Buddleia officinalis or fractions thereof Download PDF

Info

Publication number
KR20180001652A
KR20180001652A KR1020160079363A KR20160079363A KR20180001652A KR 20180001652 A KR20180001652 A KR 20180001652A KR 1020160079363 A KR1020160079363 A KR 1020160079363A KR 20160079363 A KR20160079363 A KR 20160079363A KR 20180001652 A KR20180001652 A KR 20180001652A
Authority
KR
South Korea
Prior art keywords
skin
skin barrier
lotion
acacetin
extract
Prior art date
Application number
KR1020160079363A
Other languages
Korean (ko)
Other versions
KR102298335B1 (en
Inventor
김민지
강승현
김연준
Original Assignee
코스맥스 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 코스맥스 주식회사 filed Critical 코스맥스 주식회사
Priority to KR1020160079363A priority Critical patent/KR102298335B1/en
Publication of KR20180001652A publication Critical patent/KR20180001652A/en
Application granted granted Critical
Publication of KR102298335B1 publication Critical patent/KR102298335B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/046Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof

Abstract

The present invention relates to a cosmetic composition for reinforcing skin barrier comprising an extract of Buddleja officinalis or acacetin isolated therefrom as an active ingredient. According to the present invention, the cosmetic composition comprising an extract of Buddleja officinalis or acacetin isolated therefrom as an active ingredient increases expression of genes having a skin barrier reinforcing function, thereby being capable of reinforcing skin barrier.

Description

밀몽화 추출물 또는 이의 분획물을 유효성분으로 함유하는 피부장벽강화용 화장료 조성물{Cosmetic composition for skin barrier comprising extract of Buddleia officinalis or fractions thereof} TECHNICAL FIELD The present invention relates to a cosmetic composition for enhancing skin barrier comprising extracts of wheat straw or a fraction thereof as an active ingredient,

본 발명은 밀몽화 추출물 또는 이의 분획물을 유효성분으로 함유하는 피부장벽강화용 화장료 조성물에 관한 것으로, 더욱 구체적으로 밀몽화 추출물 또는 그로부터 분리된 아카세틴(acacetin)을 유효성분으로 함유하는 피부장벽강화용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for enhancing skin barrier containing an extract of wheat seed or a fraction thereof as an active ingredient and more particularly to a cosmetic composition for enhancing skin barrier containing an extract of wheat seed or acacetin isolated therefrom as an active ingredient To a cosmetic composition.

피부장벽은 죽은 각질세포와 세포 간 지질로 구성되어 있고, 외부 자극으로부터 피부를 보호하며 피부에서 수분이 증발하는 것을 막아주는 피부 보호막으로서 피부건강에 핵심적인 기능을 담당한다. 즉, 체내에서 지나친 수분 방출을 막고 화학물질이나 미생물처럼 해로운 물질이 우리 몸 안으로 들어오는 것을 막아준다. 죽은 각질세포의 표면을 구성하는 각질세포 외피에는 세포 간 지질의 안정성에 중요한 역할을 한다. 각질형성세포는 분화를 통해 각질화 과정을 통해 피부 장벽을 만든다. 피부 장벽 기능은 노화가 진행되거나 외부 요소들에 의해 파괴될 수 있으며, 피부 장벽의 손상은 피부 수분량 감소와 주름을 일으킬 수 있다. 또한 밀착연접(tight junction)은 세포연접의 한 종류로 occludin, claudin, zona occluden(ZO) 등으로 구성되어 있다. 밀착연접은 세포막에 포함된 부분과 세포내 부분으로 나눌 수 있는데, occludin과 claudin은 세포막에 포함된 밀착연접 구성 단백질이다. 이러한 밀착연접은 세포 간의 연결고리로 이웃한 세포와 세포 사이의 간격을 메워주고 작은 물질들의 이동을 조절하는 역할도 담당한다. 최근, 연구결과를 통해 밀착연접이 피부 장벽 기능에 있어서 중요한 역할을 담당하고 있다고 보고되었다. (Aileen S. et al., Journal of Cell Science, 122 (9), 1285, 2009)Skin barrier is composed of dead keratinocyte and intercellular lipids, protects skin from external stimuli, and protects skin from evaporation of water. It is a skin barrier that plays a key role in skin health. In other words, it prevents excessive release of water in the body and prevents harmful substances such as chemicals and microorganisms from entering our bodies. It plays an important role in intercellular lipid stability in keratinocyte envelope, which constitutes the surface of dead keratinocytes. The keratinocytes undergo differentiation to form a skin barrier through the keratinization process. Skin barrier function can be aged or destroyed by external factors, and damage to the skin barrier can cause skin moisture loss and wrinkles. The tight junction is a kind of cell junction, composed of occludin, claudin, zona occluden (ZO) and so on. The tight junction can be divided into a part of the cell membrane and an intracellular part. Occludin and claudin are tight junction proteins contained in the cell membrane. This tight junction is responsible for filling the gap between neighboring cells with the intercellular linkage, and also regulating the movement of small molecules. Recently, it has been reported that tight junctions play an important role in skin barrier function. (Aileen S. et al., Journal of Cell Science, 122 (9), 1285, 2009)

아쿠아포린은 물 분자만을 선택적으로 통과시키며 모든 세포막에 존재하는 막관통단백질로 피부의 수분 흡수를 증가시키는 기작이 있다. 포유동물에서는 13가지 종류가 알려져 있고, 이들 중 아쿠아포린 3은 피부의 각질형성세포에서 발현하며 아쿠아포린 3을 통한 물과 글리세롤의 흡수와 이동은 세포의 수분 손실을 방지해 피부 탄력을 증가시킨다. (Ji Li et al., Australasian Journal of Dermatology, 51, 106, 2010)Aquaporin is a membrane-penetrating protein that selectively passes through water molecules and is present in all cell membranes, and has a mechanism to increase water absorption of the skin. In mammals, thirteen kinds are known, of which aquaporin 3 is expressed in the keratinocytes of the skin, and absorption and migration of water and glycerol through aquaporin 3 prevent cell water loss and increase skin elasticity. (Ji Li et al., Australasian Journal of Dermatology, 51, 106, 2010)

본 발명에서, “밀몽화”(Buddleia officinalis)는 마전과에 속한 낙엽 관목으로 전통적으로 간이 허해 눈이 잘 보이지 않는 병중에 주로 사용되었으며, 밀몽화의 생물학적 효능으로는 항염, 항균, 항암, 미백, 항산화 (Houghton P. J. et al., Journal of Ethnopharmacology, 100, 100-107, 2005) 효과 등이 알려져 있다. 현재 알려진 밀몽화의 성분으로는 플라보노이드로 linarin, acaciin, acacetin 등이 있다. (Li J. et al., Zhongguo Zhong Yao Za Zhi, 22(10), 613, 1997) In the present invention, "Buddleia officinalis" (Buddleia officinalis) is a deciduous shrub belonging to the Majeon family. It has been traditionally used in illnesses in which the liver is not easily visible. The biological effects of the wheat dream include anti-inflammation, Antioxidant (Houghton PJ et al., Journal of Ethnopharmacology, 100, 100-107, 2005). Currently known components of the wheat flour are flavonoids such as linarin, acaciin, and acacetin. (Li J. et al., Zhongguo Zhong Yao Za Zhi, 22 (10), 613, 1997)

그러나 밀몽화 추출물, 밀몽화 성분인 acacetin의 보습 효능과 피부장벽 개선에 관한 연구는 보고된 바 없다.However, there has been no report on the improvement of moisturizing effect and skin barrier of wheat extract, acne, acacetin.

이에, 본 발명자들은 상기 종래기술들의 문제점들을 극복하기 위하여 연구 노력한 결과, 밀몽화 추출물 또는 그로부터 분리된 acacetin을 유효성분으로 포함하는 화장료 조성물의 경우, 피부장벽강화기능을 담당하고 있는 유전자 발현을 증가시킴으로써 피부장벽을 강화할 수 있음을 확인하고, 본 발명을 완성하게 되었다.As a result, the present inventors have made efforts to overcome the problems of the prior art. As a result, in the case of a cosmetic composition comprising wheat extract or acacetin isolated therefrom as an active ingredient, The skin barrier can be strengthened, and the present invention has been completed.

Aileen S. et al., Journal of Cell Science, 122 (9), 1285, 2009 Aileen S. et al., Journal of Cell Science, 122 (9), 1285, 2009 Ji Li et al., Australasian Journal of Dermatology, 51, 106, 2010 Ji Li et al., Australasian Journal of Dermatology, 51, 106, 2010 Houghton P. J. et al., Journal of Ethnopharmacology, 100, 100-107, 2005 Houghton P. J. et al., Journal of Ethnopharmacology, 100, 100-107, 2005 Li J. et al., Zhongguo Zhong Yao Za Zhi, 22(10), 613, 1997 Li J. et al., Zhongguo Zhong Yao Za Zhi, 22 (10), 613, 1997

따라서, 본 발명의 주된 목적은 피부장벽강화 기능을 담당하고 있는 유전자 발현을 증가시킴으로써 피부장벽을 강화할 수 있는 밀몽화 추출물 또는 이의 분획물을 유효성분으로 함유하는 피부장벽강화용 화장료 조성물을 제공하는 데 있다.Accordingly, it is a main object of the present invention to provide a cosmetic composition for enhancing skin barrier containing an extract of wheat seed extract or a fraction thereof as an active ingredient capable of enhancing skin barrier by increasing gene expression responsible for skin barrier strengthening function .

본 발명의 한 양태에 따르면, 본 발명은 밀몽화 추출물 또는 그로부터 분리된 아카세틴(acacetin)을 유효성분으로 함유하는 피부장벽강화용 화장료 조성물을 제공한다.According to one aspect of the present invention, there is provided a cosmetic composition for enhancing skin barrier containing an extract of wheatronium or acacetin separated therefrom as an active ingredient.

본원발명의 상기 용어 ‘피부장벽강화’란 피부의 가장 외각에 위치하는 각질층의 장벽기능을 강화하는 것을 의미한다. 피부장벽은 죽은 각질세포와 세포 간 지질로 구성되어 있고, 외부 자극으로부터 피부를 보호하며 피부에서 수분이 증발하는 것을 막아주는 피부 보호막으로서 피부건강에 핵심적인 기능을 담당한다. 또한, 각질형성세포는 분화 및 각질화 과정을 통해 피부 장벽을 만든다. 피부 장벽 기능은 노화가 진행되거나 외부 요소들에 의해 파괴될 수 있으며, 피부 장벽의 손상은 피부 수분량 감소와 주름을 일으킬 수 있다. 본 발명에서는 본원발명의 밀몽화 추출물 또는 아카세틴은 세포간의 간격을 채워주고 물질 이동을 조절하는 밀착구조물 단백질의 유전자와 표피층의 증식 및 분화과정을 통해 완전한 각질층을 만들어주는 유전자 및 피부 각막화를 형성해주는 유전자의 발현을 증가시킴으로써, 피부 외각에 위치하는 각질층의 장벽을 강화시킨다.The term " skin barrier enhancement " of the present invention means strengthening the barrier function of the stratum corneum at the outermost part of the skin. Skin barrier is composed of dead keratinocyte and intercellular lipids, protects skin from external stimuli, and protects skin from evaporation of water. It is a skin barrier that plays a key role in skin health. In addition, keratinocytes make skin barrier through differentiation and keratinization processes. Skin barrier function can be aged or destroyed by external factors, and damage to the skin barrier can cause skin moisture loss and wrinkles. In the present invention, the whey extract or acacetin according to the present invention is a gene which forms a complete stratum corneum through the process of proliferating and differentiating the epidermal layer and the gene of the closely packed structure protein which fills the intercellular space and controls the mass transfer, By increasing the expression of the gene, it enhances the barrier of the stratum corneum, which is located in the outer skin.

본 발명에 있어서, 상기 밀몽화 추출물은 종래에 천연식물을 추출하기 위한 어떠한 용매로도 추출될 수 있으며, 바람직하게는 물, 탄소수 1 내지 4의 저급알코올, 부틸렌글리콜, 프로필렌글리콜, 글리세린 또는 이들의 혼합용매로 추출하는 것을 특징으로 한다.In the present invention, the wheat extract may be extracted with any solvent for extracting natural plants, and preferably water, lower alcohols having 1 to 4 carbon atoms, butylene glycol, propylene glycol, glycerin or the like And the like.

본 발명에 있어서, 상기 아카세틴은 밀몽화를 물, 탄소수 1 내지 4의 알코올 및 이들의 혼합용매 중 선택된 어느 하나 이상의 용매로 추출하여 얻어진 밀몽화 추출물에 실리콘겔 크로마토그래피에 의하여 분획하여 얻어진 것을 특징으로 한다. 상기 크로마토그래피에서 이동상으로는 클로로포름, 메탄올, n-헥산, 에틸아세테이트 또는 이들의 혼합용매를 이용할 수 있으며, 바람직하게는 디클로로메탄 및 메탄올의 혼합용매를 이용할 수 있다. 상기 크로마토그래피는 아카세틴이 정제될 때까지 1회 ~ 수회에 걸쳐 수행할 수 있으며, 필요에 따라 농축, 재결정을 실시할 수 있다.In the present invention, the acacetin is obtained by fractionating the wheat mononuclearum by a silicone gel chromatography on a wheat-germ extract obtained by extracting with a solvent selected from water, an alcohol having 1 to 4 carbon atoms and a mixed solvent thereof . In the above chromatography, chloroform, methanol, n-hexane, ethyl acetate or a mixed solvent thereof may be used as the mobile phase, and a mixed solvent of dichloromethane and methanol may be preferably used. The chromatography can be carried out once to several times until the acacetin is purified, and concentration and recrystallization can be carried out if necessary.

본 발명에 있어서, 상기 밀몽화 추출물 또는 아카세틴은 조성물 종 중량대비 0.001 내지 50 중량% 함유하는 것을 특징으로 한다.In the present invention, the whey extract or acacetin is contained in an amount of 0.001 to 50% by weight based on the weight of the composition.

본 발명의 실험예에 따르면, 본 발명의 밀몽화 추출물 또는 그 분획물인 아카세틴은 표피층의 증식과 분화과정을 통해 완전한 각질층을 만드는 유전자인 필라그린과 피부각막화 형성에 관여하는 트랜스글루타미나아제-1 및 세포와 세포의 간격을 채워주고 물질 이동을 조절하는 밀착구조물 유전자인 클라우딘-1의 발현을 증가시키는 것을 확인하였다. 또한, 인공피부를 통해서도 보습인자인 아쿠아포린 3과 필라그린의 발현을 증가시키는 것을 확인하였다. 이러한 결과로 볼 때, 본 발명의 밀몽화 추출물 또는 아카세틴은 피부장벽기능을 강화시키는 유전자들의 발현을 증가시킴으로써 피부 최외각층의 수분 흡수를 증가시키고 각질 형성세포 간의 연결고리를 증가시킬 뿐만 아니라 각질층과 세포를 강화시켜 결론적으로는 피부장벽기능을 개선시킬 수 있음을 알 수 있다(실험예 1-2 참조).According to the experimental example of the present invention, acacetin, which is the wheat extract of the present invention or its fraction, has a pilar green which is a gene which forms a complete stratum corneum through proliferation and differentiation of the epidermal layer and transglutaminase -1 and the expression of clodin-1, a close-coupled structural gene that fills the gap between cells and cells and controls mass transfer. In addition, it was confirmed that the expression of aquaporin 3 and pilgar green, which are moisturizing factors, is also increased through artificial skin. As a result, the whey extract or acacetin of the present invention increases the expression of genes that enhance the skin barrier function, thereby increasing the moisture absorption of the outermost layer of the skin and increasing the inter-keratinocyte ligation, Cells can be strengthened and consequently skin barrier function can be improved (see Experimental Example 1-2).

본 발명에 있어서, 상기 화장료 조성물은 화장수(스킨로션), 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양 로션, 마사지 크림, 영양 크림, 모이스쳐 크림, 핸드크림, 파운데이션, 에센스, 영양 에센스, 팩, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클렌저로 구성된 군에서 선택된 하나 이상의 제형을 갖는 것을 특징으로 한다.In the present invention, the cosmetic composition according to the present invention may be used as a skin lotion, a skin softener, a skin toner, an astringent, a lotion, a milk lotion, a moisturizing lotion, a nutrition lotion, a massage cream, And at least one selected from the group consisting of nutritional essence, pack, soap, cleansing foam, cleansing lotion, cleansing cream, body lotion and body cleanser.

본 발명의 화장료 조성물에 포함되는 성분은 유효성분으로서 상기 추출물 이외에 화장료 조성물에 통상적으로 이용되는 성분들을 포함할 수 있으며, 예를 들면, 안정화제, 용해화제, 비타민, 안료 및 향료와 같은 통상적인 보조제 및 담체를 포함한다.The ingredients contained in the cosmetic composition of the present invention may contain, in addition to the above-mentioned extracts, the components conventionally used in cosmetic compositions, such as stabilizers, solubilizers, vitamins, pigments and fragrances, And a carrier.

이상 설명한 바와 같이, 본 발명의 밀몽화 추출물 또는 그의 분획물인 아카세틴은 피부장벽기능을 강화시키는 유전자인 필라그린, 트랜스글루타미나제-1, 클라우딘-1 및 아쿠아포린-3의 발현을 증가시킴으로써, 피부장벽을 강화 및 개선 시킬 수 있다.As described above, the wheat extract of the present invention or a fraction thereof, acacetin, increases the expression of filaggrin, transglutaminase-1, claudin-1 and aquaporin-3, genes that enhance skin barrier function , Skin barrier can be enhanced and improved.

도 1은 acacetin의 화학식을 나타낸다.
도 2는 밀몽화 추출물, acacetin 처리 시 아쿠아포린3 유전자의 발현을 보여주는 그래프이다.
도 3은 밀몽화 추출물, acacetin 처리 시 필라그린 유전자의 발현을 보여주는 그래프이다.
도 4은 밀몽화 추출물, acacetin 처리 시 트랜스글루타미나제1 유전자의 발현을 보여주는 그래프이다.
도 5은 밀몽화 추출물, acacetin 처리 시 클라우딘1 유전자의 발현을 보여주는 그래프이다.
도 6은 밀몽화 추출물, acacetin 처리 시 인공피부에서 아쿠아포린3, 필라그린의 발현을 보여주는 시각적 효과를 입증하는 것이다.
Figure 1 shows the formula of acacetin.
FIG. 2 is a graph showing the expression of the aquaporin 3 gene during the treatment with the wheat extract, acacetin.
FIG. 3 is a graph showing the expression of a pilana green gene in the treatment with wheatronium extract, acacetin.
FIG. 4 is a graph showing the expression of transglutaminase gene 1 in the treatment with wheat extract, acacetin.
FIG. 5 is a graph showing the expression of the Claudin 1 gene when treated with the wheat extract, acacetin.
Figure 6 demonstrates the visual effect of the expression of aquaporin 3 and pilgar green on artificial skin in the treatment of wheat seed extract, acacetin.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하기로 한다. 이들 실시예는 단지 본 발명을 예시하기 위한 것이므로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다.Hereinafter, the present invention will be described in more detail with reference to Examples. These embodiments are only for illustrating the present invention, and thus the scope of the present invention is not construed as being limited by these embodiments.

실시예 1: 밀몽화 추출물의 제조Example 1: Preparation of a wheat starch extract

밀몽화는 경동시장(서울, 한국)에서 구입한 것을 건조하여 사용하였다. 상기 건조시킨 밀몽화를 분말화 한 후, 각 10g당 70% 에탄올 100㎖을 가한 후, 상온에서 1일간 숙성시켰다. 그 다음, 상기 추출물을 순차적으로 여과하고 감압농축하여 추출물을 제조하였다.Milonghwa was purchased from Kyungdong market (Seoul, Korea) and dried. After the dried wheat flour was pulverized, 100 ml of 70% ethanol was added to each 10 g, and the mixture was aged at room temperature for 1 day. Then, the extract was sequentially filtered and concentrated under reduced pressure to prepare an extract.

실시예Example 2:  2: Acacetin의Acacetin 제조 Produce

Acacetin은 n-butanol 용매로 추출한 밀몽화 추출물에서 크로마토그래피 실리카겔 칼럼을 이용하여 분획을 얻어 제조하였다. 분획 용매 조건은 dichloromethane/methanol (30:1→0:1, v=v)과 같다. 또한 UV 흡수파장을 acacetin 표준품과 비교한 결과 위 분획물이 acacetin임을 확인할 수 있었다.Acacetin was prepared from the wheat extract extracted with n-butanol as a solvent using a chromatographic silica gel column. The fraction solvent conditions are the same as dichloromethane / methanol (30: 1 → 0: 1, v = v). In addition, UV absorption wavelength was compared with acacetin standard and it was confirmed that the above fraction was acacetin.

실험예Experimental Example 1:  One: 각질형성세포주에서In keratinocyte cell line 유전자 발현 확인 Confirm gene expression

1-1: 1-1: 인간피부Human skin 각질형성세포주Keratinocyte cell line HaCaTHaCaT 세포 배양 Cell culture

인간피부의 구성 세포주인 각질형성세포 HaCaT는 10% fetal bovine serum (FBS)과 항생제가 들어있는 DMEM 배양액을 사용하여 배양하였다. 배양 용기는 75T-flask와 6 well plate를 사용하였으며 5% CO2가 공급되는 37℃ 배양기에서 배양하였다. 배양액은 3~4일마다 교환해 주며 세포가 과다하게 증식되었을 때는 계대배양 하였다. HaCaT(5*105/well)을 분주하고 배양 24 시간 후, 인산 완충 식염수 용액(PBS)로 세척하고, 각 웰에 FBS를 넣지 않은 DMEM 배지에 밀몽화 추출물과 acacetin을 각각 10 ppm이 되도록 희석시켜 각 웰에 첨가하였다. 24 시간 후 cDNA를 합성하고 PCR을 실시하여 유전자 발현 정도를 평가하였다.The keratinocyte HaCaT, a constitutive cell line of human skin, was cultured in a DMEM culture medium containing 10% fetal bovine serum (FBS) and antibiotics. The cells were cultured in a 75 ° C flask and a 6-well plate at 37 ° C with 5% CO 2 . The culture medium was changed every 3 to 4 days. When the cells were overproduced, they were subcultured. HaCaT (5 * 10 5 / well) was added and diluted to 10 ppm with DMEM medium without FBS in each well after 24 hours of incubation and washed with phosphate buffered saline (PBS) To each well. After 24 hours, cDNA was synthesized and PCR was performed to evaluate gene expression level.

1-2: Real-time 1-2: Real-time PCR을PCR 이용한 보습 인자, 장벽 개선 인자 유전자 발현 시험 Use of moisturizing factor, barrier improvement factor gene expression test

합성된 cDNA를 타겟 주형(primer) 및 시아닌 염료인 SYBR 그린(green) 마스터 혼합물(master mix)을 사용하여 실시간(real-time) 중합효소 연쇄반응(PCR)을 실시하여 최종적으로 유전자 발현 정도를 평가하였다. 유전자에 관한 발현은 Ct(threshold cycle) 방법에 의한 내부 대조 유전자 β-actin의 보정 정량화를 통한 상대적인 값으로 비교되었으며 서열은 아래 표 1에서 볼 수 있다. (음성 대조군에 대하여 *: p<0.05, **: p<0.01) The synthesized cDNA was subjected to real-time PCR (PCR) using a master mix and a SYBR green master mix as a target template and a cyanine dye to finally evaluate gene expression level Respectively. Expression of the gene was compared with the relative value by calibrated quantification of the internal control gene β-actin by the Ct (threshold cycle) method, and the sequence is shown in Table 1 below. (*: P < 0.05, **: p < 0.01 for negative control)

프라이머 이름Name of the primer 서열order Aquaporin3Aquaporin3 정방향 5'-AGACAGCCCCTTCAGGATTT-3'Forward 5'-AGACAGCCCCTTCAGGATTT-3 ' Aquaporin3Aquaporin3 역방향 5'-TCCCTTGCCCTGAATATCTG-3'Reverse 5'-TCCCTTGCCCTGAATATCTG-3 ' FilaggrinFilaggrin 정방향 5'-TAGTGCACTCAGGGGGCTCACA-3' Forward 5'-TAGTGCACTCAGGGGGCTCACA-3 ' FilaggrinFilaggrin 역방향 5'-TCCGGCTTGGCCGTAATGTGT-3' Reverse 5'-TCCGGCTTGGCCGTAATGTGT-3 ' Transglutaminase1Transglutaminase 1 정방향 5'-CCCCAAGAGACTAGCAGTGG-3'Forward 5'-CCCCAAGAGACTAGCAGTGG-3 ' Transglutaminase1Transglutaminase 1 역방향 5'-AGACCAGGCCATTCTTGATG-3'Reverse 5'-AGACCAGGCCATTCTTGATG-3 ' Claudein1Claudein1 정방향 5'-GCTCTAGAATTCCGAGCGAGTCATGGCCAACGC-3'Forward 5'-GCTCTAGAATTCCGAGCGAGTCATGGCCAACGC-3 ' Claudein1Claudein1 역방향 5'-GCTCTAGAATTCTCACACGTAGTCTTTCCCGCT-3'Reverse 5'-GCTCTAGAATTCTCACACGTAGTCTTTCCCGCT-3 ' β-actinβ-actin 정방향 5'-GGCCATCTCTTGCTCGAAGT-3'Forward 5'-GGCCATCTCTTGCTCGAAGT-3 ' β-actinβ-actin 역방향 5'-GACACCTTCAACACCCCAGC-3'Reverse 5'-GACACCTTCAACACCCCAGC-3 '

그 결과, 도 2에 나타낸 바와 같이, 밀몽화 추출물과 acacetin 10 ppm 처리에 따라 아쿠아포린3 발현양이 유의적으로 증가함을 확인할 수 있었다. 따라서, 아쿠아포린3의 증가는 세포간의 부착과 세포주위 공간을 통한 수분 이동의 조절을 더 효과적으로 수행할 수 있음을 나타냄으로써 보습기능을 강화할 수 있다.As a result, as shown in FIG. 2, it was confirmed that the amount of aquaporin 3 expression was significantly increased by treatment with wheat extract and acacetin 10 ppm. Thus, an increase in aquaporin 3 can enhance the moisturizing function by showing that it can more effectively control intercellular adhesion and water movement through the periplasmic space.

또한, 도 3에서 확인할 수 있듯이 필라그린의 증가는 표피층의 증식과 분화의 과정을 통해 완전한 각질층을 만듦을 의미한다. 이를 통하여, 본 발명에서는 밀몽화 추출물, acacetin은 피부 장벽 개선을 통해 수분보유능력을 증진시켜 피부 보습에 탁월한 효과를 나타낼 것으로 생각된다. In addition, as shown in FIG. 3, the increase in the pillared green means that the stratum corneum is formed through the process of proliferation and differentiation of the epidermal layer. Thus, in the present invention, acacetin, which is an extract of wheat strawberry, is expected to exhibit an excellent effect on skin moisturization by improving the water retention ability by improving the skin barrier.

더욱이, 도 4, 5에 확인할 수 있듯이 피부 각화막(cornified envelope) 형성에 결정적인 역할을 수행하는 트랜스글루타미나제 1 유전자의 발현을 증가시키고, 외부 환경으로부터 내부기관을 보호하고 인체의 항상성을 유지하는 역할을 담당하는 밀착연접의 구조물인 클라우딘 1의 발현을 증가시킨다. 따라서 이는 세포간의 부착과 세포주위 공간을 통한 수분 함유의 용질 및 수분의 이동의 조절을 더 효과적으로 수행할 수 있음을 나타냄으로써 피부장벽기능을 강화할 수 있다. Furthermore, as can be seen in FIGS. 4 and 5, the expression of transglutaminase 1 gene, which plays a crucial role in the formation of a corneal envelope, is increased, the internal organ is protected from the external environment, The expression of clathrin-1, which is a construct of tight junctions, Therefore, it can enhance the skin barrier function by showing that it can more effectively perform the adhesion between cells and the control of the migration of water-containing solute and moisture through the periplasmic space.

실험예Experimental Example 2: 피부의 조직학적 관찰 2: Histopathological observation of skin

2-1. 인공피부 배양2-1. Artificial skin culture

밀몽화 추출물, acacetin에 의한 보습인자 발현 정도를 인간피부와 유사하도록 재현한 삼차원 배양피부 모델 (RHE: Reconstructed Human Epidermis)에서 확인하였다. RHE가 도착하면 안정화를 위해 growth medium에 24시간 배양 후, 밀몽화 추출물, acacetin을 10 ppm 처리한다.(RHE: Reconstructed Human Epidermis) in which the degree of moisturizing factor expression by acacetin was reproduced similar to that of human skin. When RHE arrives, it is cultured in growth medium for 24 hours for stabilization and treated with 10 ppm of wheat extract, acacetin.

2-2: 면역염색법을 이용한 2-2: Immunostaining 아쿠아포린3Aquaporin 3  And 필라그린Pillar Green 발현 영향 시험 Expression test

배양 3일 후 적출한 피부 조직을 10% 포르말린 용액에 고정한 후, 파라핀으로 포매하고 절편을 잘라 조직면역염색법을 수행하였다. Three days after the culture, the skin tissue was fixed in 10% formalin solution, embedded in paraffin, cut into sections and subjected to tissue immunostaining.

그 결과, 도 6에 나타난바와 같이 대조군((-))에 비해 밀몽화 추출물, acacetin을 처리한 군은 아쿠아포린 3과 필라그린이 증가되었음을 확인할 수 있었다. 또한 기저층의 배열이 더 규칙적으로 배열되고 표피층이 두꺼워짐을 확인할 수 있었다. 따라서 이는 피부 조직학적으로도 밀몽화 추출물, acacetin이 피부 장벽 개선에 효과가 있음을 확인할 수 있다.As a result, as shown in FIG. 6, it was confirmed that the whey extract and acacetin-treated aqua purine 3 and fila green were increased in comparison with the control group (-). It was also confirmed that the arrangement of the basal layers was arranged more regularly and the skin layer became thicker. Therefore, it can be confirmed that acne extract, acacetin, is effective for improving skin barrier.

Claims (5)

밀몽화 추출물 또는 그로부터 분리된 아카세틴(acacetin)을 유효성분으로 함유하는 피부장벽강화용 화장료 조성물.
A cosmetic composition for enhancing skin barrier comprising an extract of wheat straw or acacetin separated therefrom as an active ingredient.
제 1항에 있어서, 상기 밀몽화 추출물은 물, 탄소수 1 내지 4의 저급알코올, 부틸렌글리콜, 프로필렌글리콜, 글리세린 또는 이들의 혼합용매로 추출하는 것을 특징으로 하는 피부장벽강화용 화장료 조성물.
The cosmetic composition for skin barrier strengthening according to claim 1, wherein the whey extract is extracted with water, a lower alcohol having 1 to 4 carbon atoms, butylene glycol, propylene glycol, glycerin or a mixed solvent thereof.
제 1항에 있어서, 상기 아카세틴은 밀몽화를 물, 탄소수 1 내지 4의 알코올 및 이들의 혼합용매 중 선택된 어느 하나 이상의 용매로 추출하여 얻어진 밀몽화 추출물에 실리콘겔 크로마토그래피에 의하여 분획하여 얻어진 것을 특징으로 하는 피부장벽강화용 화장료 조성물.
The acacetin according to claim 1, wherein the acacetin is obtained by extracting a wheat mononucleotide with a solvent selected from the group consisting of water, an alcohol having 1 to 4 carbon atoms, and a mixed solvent thereof, and isolating the resulting whey extract by silicone gel chromatography Wherein the skin barrier enhances the skin barrier property.
제 1항에 있어서, 상기 밀몽화 추출물 또는 아카세틴은 조성물 종 중량대비 0.001 내지 50 중량%함유하는 것을 특징으로 하는 피부장벽강화용 화장료 조성물.
The cosmetic composition for skin barrier strengthening according to claim 1, wherein the whey extract or acacetin is contained in an amount of 0.001 to 50 wt% based on the weight of the composition.
제 1항에 있어서, 상기 화장료 조성물은 화장수(스킨로션), 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양 로션, 마사지 크림, 영양 크림, 모이스쳐 크림, 핸드크림, 파운데이션, 에센스, 영양 에센스, 팩, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디로션 및 바디클렌저로 구성된 군에서 선택된 하나 이상의 제형을 갖는 것을 특징으로 하는 피부장벽강화용 화장료 조성물.The cosmetic composition according to claim 1, wherein the cosmetic composition is at least one selected from the group consisting of a lotion (skin lotion), a skin softener, a skin toner, an astringent, a lotion, a milk lotion, a moisturizing lotion, a nutrition lotion, a massage cream, Wherein the composition has at least one formulation selected from the group consisting of nutritional essence, pack, soap, cleansing foam, cleansing lotion, cleansing cream, body lotion and body cleanser.
KR1020160079363A 2016-06-24 2016-06-24 Cosmetic composition for skin barrier comprising extract of Buddleia officinalis or fractions thereof KR102298335B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160079363A KR102298335B1 (en) 2016-06-24 2016-06-24 Cosmetic composition for skin barrier comprising extract of Buddleia officinalis or fractions thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160079363A KR102298335B1 (en) 2016-06-24 2016-06-24 Cosmetic composition for skin barrier comprising extract of Buddleia officinalis or fractions thereof

Publications (2)

Publication Number Publication Date
KR20180001652A true KR20180001652A (en) 2018-01-05
KR102298335B1 KR102298335B1 (en) 2021-09-07

Family

ID=61001701

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160079363A KR102298335B1 (en) 2016-06-24 2016-06-24 Cosmetic composition for skin barrier comprising extract of Buddleia officinalis or fractions thereof

Country Status (1)

Country Link
KR (1) KR102298335B1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110538101A (en) * 2018-05-29 2019-12-06 伽蓝(集团)股份有限公司 Application of alcohol extract of buddleja officinalis
KR20210036649A (en) 2019-09-26 2021-04-05 주식회사 비앤에이치웍스 Cosmetic composition containing skin strengthening composition and method for producing same
KR20210101559A (en) * 2020-02-10 2021-08-19 한국과학기술연구원 Composition for preventing, improving or treating atopic dermatitis comprising linarin or acacetin

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001199862A (en) * 2000-01-14 2001-07-24 Ichimaru Pharcos Co Ltd Cosmetic composition containing moisture retention plant extract

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001199862A (en) * 2000-01-14 2001-07-24 Ichimaru Pharcos Co Ltd Cosmetic composition containing moisture retention plant extract

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Aileen S. et al., Journal of Cell Science, 122 (9), 1285, 2009
Houghton P. J. et al., Journal of Ethnopharmacology, 100, 100-107, 2005
Ji Li et al., Australasian Journal of Dermatology, 51, 106, 2010
Journal of natural products. Vol.62, No.9, pp.1241-1245 (1999.09. 공개)* *
Li J. et al., Zhongguo Zhong Yao Za Zhi, 22(10), 613, 1997

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110538101A (en) * 2018-05-29 2019-12-06 伽蓝(集团)股份有限公司 Application of alcohol extract of buddleja officinalis
KR20210036649A (en) 2019-09-26 2021-04-05 주식회사 비앤에이치웍스 Cosmetic composition containing skin strengthening composition and method for producing same
KR20210101559A (en) * 2020-02-10 2021-08-19 한국과학기술연구원 Composition for preventing, improving or treating atopic dermatitis comprising linarin or acacetin

Also Published As

Publication number Publication date
KR102298335B1 (en) 2021-09-07

Similar Documents

Publication Publication Date Title
KR101651321B1 (en) Anti-aging and Enhancing Skin Barrier Function composition for skin external application comprising Aloe vera Placenta Cell Culture Extract
JP2011088845A (en) Involucrin expression inhibitor
KR20180001652A (en) Cosmetic composition for skin barrier comprising extract of Buddleia officinalis or fractions thereof
JP5714956B2 (en) Collagen production promoter
CN110072516A (en) Cosmetic combination comprising the Chinese medicinal material extract as effective component
KR20190017084A (en) Cosmetic composition containing Soybean extracts promoting Ceramide biosynthesis and enhancing Skin Barrier
KR101221875B1 (en) Cosmetic compositions comprising the extract of acer tegmentosum for enhancing collagen Biosynthesis
KR20080093500A (en) Cosmetic compositions for preventing skin aging comprising extract astilbe chinensis var. davidii
KR20080085432A (en) Whitening cosmetic composition comprising an extract of halocynthia sp. shell
KR102168534B1 (en) Cosmetic composition for enhancing skin elasticity or improving skin wrinkle containing herb extracts
KR102008485B1 (en) Cosmetic Composition for skin moisturizing comprising Aquilaria agallocha Roxburgh extracts
KR102178888B1 (en) Cosmetic composition for enhancing skin elasticity or improving skin wrinkle containing herb extracts
KR102047461B1 (en) Composition for improving wrinkle comprising Symplocarpus foetidus extract or fractions thereof
KR102017132B1 (en) Cosmetic composition comprising a mixed fermentation extract of cinnamomum verum and angelica dahurica
JP2011088854A (en) Involucrin expression inhibitor
KR101926179B1 (en) Cosmetic composition containing canavalia lineata extract for moisturizing and anti-wrinkle effects on the skin
KR20100093223A (en) Cosmetic composition containing an extract of ophiopogon japonicus for skin miosture
KR101581285B1 (en) Skin anti-wrinkle cosmetic composition containing mixed medicinal herb extract
KR20190130543A (en) Composition for improving wrinkle comprising Symplocarpus foetidus extract or fractions thereof
EP3381441B1 (en) External use skin composition for antiaging containing germinated glycine gracilis extract as active ingredient
KR102629711B1 (en) Cosmetic Composition Comprising Exosome isolated From Dioscorea Japonica Thunb. As Active Ingredient
KR102229902B1 (en) A skin hydration and skin barrier improvement cosmetic composition comprising a mixed extract containing an active ingredient of a phenolic compound
KR102168531B1 (en) Cosmetic composition for enhancing skin elasticity or improving skin wrinkle containing herb extracts
KR102606380B1 (en) Composition for enhancing skin barrier containing Bolboschoenus planiculmis extract
KR102337422B1 (en) Cosmetic composition comprising jojoba oil for skin calming care and skin trouble improvement, and preparing method the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant